Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00928135

Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects

Randomized Controlled Study of Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Hospitalized Patients With Exacerbation of Cystic Fibrosis

Sponsor: Joseph Zabner

Conditions Cystic Fibrosis

Interventions Hypertonic saline Xylitol

Updated 8 times since 2017 Last updated: Jun 3, 2021 Started: Jan 22, 2013 Primary completion: Apr 9, 2018 Completion: Apr 9, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Cystic Fibrosis, this trial is completed. The trial is conducted by Joseph Zabner and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Sep 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Sep 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 3 earlier versions

May 2018 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

Status: Active Not Recruiting → Completed
Feb 2017 — May 2018 [monthly]

Active Not Recruiting PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1_PHASE2

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Joseph Zabner

Data source: University of Iowa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Iowa City, United States